List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 21 studies with search of: stem cell multiple sclerosis
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Donor Stem Cell Transplantation for the Treatment of Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Procedure: Stem cell transplant
Group: Adult
Phases: Phase I / Phase II
2 Active, not recruiting Mesenchymal Stem Cells in Multiple Sclerosis (MSCIMS)
Condition: Multiple Sclerosis
Intervention: Procedure: MSC Treatment
Group: Adult
Phases: Phase I / Phase II
3 Completed Immunological Mechanisms of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Procedure: Stem Cell Transplanataion
Age Groups: Adult / Senior
Phase: Phase II
4 Active, not recruiting Hematopoietic Stem Cell Therapy for Patients With Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Procedure: hematopoietic stem cell transplantation
Group: Adult
Phases: Phase I / Phase II
5 Recruiting Autologous Mesenchymal Stem Cells From Adipose Tissue in Patients With Secondary Progressive Multiple Sclerosis
Conditions: Autoimmune Diseases;   Immune System Diseases;   Demyelinating Diseases;   Nervous System Diseases;   Demyelinating Autoimmune Diseases, CNS;   Autoimmune Diseases of the Nervous System
Intervention: Other: Autologous mesenchymal stem cells from adipose tissue.
Age Groups: Adult / Senior
Phases: Phase I / Phase II
6 Active, not recruiting Mesenchymal Stem Cells for the Treatment of MS
Condition: Multiple Sclerosis
Intervention: Biological: injection of autologous stem cells
Group: Adult
Phases: Phase I / Phase II
7 Not yet recruiting Autologous Mesenchymal Stem Cell (MSC) Transplantation in MS
Conditions: Relapsing-Remitting Multiple Sclerosis;   Secondary Progressive Multiple Sclerosis;   Progressive Relapsing Multiple Sclerosis
Intervention: Biological: Autologous mesenchymal stem cell transplantation
Group: Adult
Phase: Phase I
8 Active, not recruiting Autologous Stem Cell Transplant for Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Other: immuno-ablation and autologous CD34 selected hematopoietic stem cell transplantation (HSCT),;   Other: Standard Therapy
Group: Adult
Phase: Phase II
9 Active, not recruiting High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) Study
Condition: Multiple Sclerosis
Interventions: Drug: Granulocyte-colony stimulating factor (G-CSF) and prednisone;   Drug: Carmustine, etoposide, cytarabine, and melphalan (BEAM);   Procedure: Autologous hematopoietic stem cell transplant
Group: Adult
Phase: Phase II
10 Recruiting Stem Cell Therapy for Patients With Multiple Sclerosis Failing Interferon A Randomized Study
Condition: Multiple Sclerosis
Intervention: Procedure: Hematopoietic Stem Cell Therapy
Group: Adult
Phase: Phase III
11 Not yet recruiting Rajavtihi Neuronal Adult Stem Cells Project
Conditions: Alzheimer's Disease;   Parkinson's Disease;   Multiple Sclerosis
Intervention: Other: Progenitor Stem Cell Culture
Age Groups: Adult / Senior
Phase: Phase II
12 Completed Phase I Study of High-Dose Cyclophosphamide and Total Body Irradiation With T Lymphocyte-Depleted Autologous Peripheral Blood Stem Cell or Bone Marrow Rescue in Patients With Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: cyclophosphamide;   Drug: filgrastim;   Drug: methylprednisolone;   Procedure: Autologous Stem Cell Transplantation
Age Groups: Child / Adult
Phase: Phase I
13 Completed Phase I Pilot Study of Total-Body Irradiation, Anti-Thymocyte Globulin and Cyclophosphamide Followed By Syngeneic or Autologous Peripheral Blood Stem Cell Transplantation in Patients With Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: anti-thymocyte globulin;   Drug: cyclophosphamide;   Drug: filgrastim;   Drug: prednisone;   Procedure: peripheral blood stem cell transplantation;   Procedure: irradiation
Group: Adult
Phase: Phase I
14 Completed High Dose Chemo/Radiotherapy and Hematopoietic Stem Cell Transplant for Patients With Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Cyclophosphamide;   Drug: ATG;   Drug: MESNA;   Procedure: Radiation therapy
Group: Adult
Phase: Phase II
15 Recruiting Oligodendrocyte Progenitor Cell Culture From Human Brain
Condition: Demyelinating Diseases
Intervention: Procedure: Oligodendrocyte progenitor cell culture/craniotomy
Group: Adult
Phase: Phase I
16 Recruiting Cord Blood Infusion for Type 1 Diabetes Mellitus (T1DM)
Conditions: Type 1 Diabetes;   Children
Intervention: Other: Umbilical Cord Blood VITA 34
Age Groups: Child / Adult / Senior
Phase: Phase I
17 Recruiting Hematopoietic Stem Cell Transplant in Devic's Disease
Condition: Devic's Disease
Intervention: Procedure: Hematopoietic stem cell transplantation
Group: Adult
Phase: Phase I
18 Recruiting Allogeneic Mesenchymal Stem Cells Transplantation for Systemic Sclerosis (SSc)
Conditions: Systemic Sclerosis;   Mesenchymal Stem Cells
Intervention: Biological: Allogeneic Mesenchymal Stem Cells (AlloMSC)
Age Groups: Child / Adult
Phases: Phase I / Phase II
19 Recruiting Scleroderma: Cyclophosphamide or Transplantation (SCOT)
Conditions: Scleroderma, Systemic;   Sclerosis;   Autoimmune Disease
Interventions: Procedure: Autologous stem cell transplantation and High-dose immunosuppressive therapy (HDIT);   Drug: Cyclosphosphamide;   Drug: Equine antithymocyte globulin;   Drug: Methylprednisolone;   Drug: Growth colony stimulating factor (G-CSF);   Radiation: Total body irradiation (TBI)
Age Groups: Adult / Senior
Phase: Phase II
20 Active, not recruiting High Dose Cyclophosphamide for Treatment of Scleroderma
Condition: Scleroderma
Intervention: Drug: High Dose Cyclophosphamide
Age Groups: Adult / Senior
Phase: Phase III

Previous Page Studies Shown (1-20) Next Page (21-21)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services